Influence of biofilm formation in the susceptibility of Pseudomonas aeruginosa from Brazilian patients with cystic fibrosis

APMIS

Volumn 118, Issue 8, 2010, Pages 606-612

  Ferreira, Alex Guerra ^a   LeÃo, Robson Souza ^a   Carvalho Assef, Ana Paula D'Alincourt ^b   Folescu, Tania Wrobel ^b   Barth, Afonso Luís ^c   Marques, Elizabeth Andrade ^a  

^a UNIVERSIDADE DO ESTADO DO RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

biofilm; cystic fibrosis; Pseudomonas aeruginosa; resistance

Indexed keywords

AMIKACIN; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; BIOFILM; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; LUNG FIBROSIS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

BIOFILMS; CYSTIC FIBROSIS; DISEASE SUSCEPTIBILITY; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 77954712323     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2010.02636.x     Document Type: Article

References (27)

1. Davies JC, Bilton D. Bugs, biofilms, and resistance in cystic fibrosis. Respir Care 2009 54 : 628 640.
2. Burns JL, Gibson RL, McNamara S, Yim D, Emerson J, Rosenfeld M, et al. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis 2001 183 : 444 452.
3. Rosenfeld M, Gibson RL, McNamara S, Emerson J, Burns JL, Castile R, et al. Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol 2001 32 : 356 366.
4. West SHE, Zeng L, Lee BL, Kosorok MR, Laxova A, Rock MJ, et al. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors. JAMA 2002 287 : 2958 2967.
5. Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clin Microbiol Rev 2002 15 : 194 222.
6. Ratjen F, Doring G. Cystic fibrosis. Lancet 2003 61 : 681 689.
7. Moreau-Marquis S, Stanton BA, O'Toole GA. Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway. Pulm Pharmacol Ther 2008 21 : 595 599.
8. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999 284 : 1318 1322.
9. Ryder C, Byrd M, Wozniak DJ. Role of polysaccharides in Pseudomonas aeruginosa biofilm development. Curr Opin Microbiol 2007 10 : 644 648.
10. Sing PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ, Greenberg EP. Quorum sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 2000 407 : 762 764.
11. Collier DN, Anderson L, McKnight SL, Noah TL, Knowles M, Boucher R, et al. A bacterial cell to cell signal in the lungs of cystic fibrosis patients. FEMS Microbiol Lett 2002 215 : 41 6.
12. Willcox MDP, Zhu H, Conibear TCR, Hume EBH, Givskov M, Kjelleberg S, et al. Role of quorum sensing by Pseudomonas aeruginosa in microbial keratitis and cystic fibrosis. Microbiology 2008 154 : 2184 2194.
13. Moskowitz SM, Foster JM, Emerson J, Burns JL. Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbiol 2004 42 : 1915 1922.
14. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard, 6th edn. Document M7-A6.
15. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995 33 : 2233 2239.
16. Landry RM, An D, Hupp JT, Singh PK, Parsek MR. Mucin-Pseudomonas aeruginosa interactions promote biofilm formation and antibiotic resistance. Mol Microbiol 2006 59 : 142 151.
17. Hall-Stoodley L, Stoodley P. Evolving concepts in biofilm infections. Cell Microbiol 2009 11 : 1034 1043.
18. Lee B, Haagensen JA, Ciofu O, Andersen JB, Hoiby N, Molin S. Heterogeneity of biofilms formed by nonmucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis. J Clin Microbiol 2005 43 : 5247 5255.
19. Drenkard E. Antimicrobial resistance of Pseudomonas aeruginosa biofilms. Microbes Infect 2003 5 : 1213 1219.
20. Mah TF, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 2001 9 : 34 9.
21. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet 2001 358 : 135 138.
22. Davey ME, O'Toole GA. Microbial biofilms: from ecology to molecular genetics. Microbiol Mol Biol Rev 2000 64 : 847 867.
23. Donlan RM. Role of biofilms in antimicrobial resistance. ASAIO J 2000 46 : S47 52.
24. Werner E, Roe F, Bugnicourt A, Franklin MJ, Heydorn A, Molin S, et al. Stratified growth in Pseudomonas aeruginosa biofilms. Appl Environ Microbiol 2004 70 : 6188 6196.
25. Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 2002 109 : 317 325.
26. Shigeta M, Tanaka G, Komatsuzawa H, Sugai M, Suginaka H, Usui T. Permeation of antimicrobial agents through Pseudomonas aeruginosa biofilms: a simple method. Chemotherapy 1997 43 : 340 345. (Pubitemid 27346061)
27. Ramsey BW, Pepe MS, Quan JM, Otto KL, Montgomery AB, Williams-Warren J, et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. N Engl J Med 1999 340 : 23 30.